BioCentury | Dec 13, 2018
Company News

Management tracks: Ambys, Foghorn

...laboratory director of the genetic testing company since joining as part of the acquisition of Clarient Inc....
BioCentury | Jan 4, 2016
Company News

General Electric, NeoGenomics deal

...NeoGenomics completed its acquisition of General Electric’s Clarient Inc. unit and Clarient’s Clarient Diagnostic Services Inc. subsidiary...
BioCentury | Dec 14, 2015
Company News

General Electric, NeoGenomics deal

...Cancer diagnostic company NeoGenomics will acquire General Electric’s Clarient Inc. unit and Clarient’s Clarient Diagnostic Services Inc...
...on NeoGenomics close of $5.68 on Oct. 20, the day before the deal was announced. Clarient...
...revenue in 2014; NeoGenomics had $87.1 million in revenue for the same period. GE acquired Clarient...
BioCentury | Nov 3, 2014
Company News

General Electric, GlaxoSmithKline deal

...General Electric's Clarient Diagnostic Services Inc. company and GlaxoSmithKline partnered to form a network of clinical...
...laboratories to identify genetic mutations associated with different tumor types. The partners will initially use Clarient's...
...focus on more than 70 melanoma-relevant mutations, including BRAF V600E and BRAF V600K. The first Clarient-certified...
BioCentury | May 5, 2014
Company News

CardioDx management update

...of corporate development and general counsel, formerly SVP of business development and product strategy at Clarient Inc....
BioCentury | Apr 30, 2014
Financial News

CardioDx revives IPO plans

...served in multiple executive management positions, including SVP of business development and product strategy at Clarient Inc....
...now part of Thermo Fisher Scientific Inc. (NYSE:TMO). Prior to that, Ross was CSO at Clarient...
BioCentury | Jan 27, 2014
Company News

Epic Sciences management update

...Jolla, Calif. Business: Diagnostic, Cancer Hired: Michael Rodriguez as CFO, formerly COO of General Electric's Clarient...
BioCentury | Oct 7, 2013
Clinical News

Oncotype DX breast cancer assay regulatory update

...to recommend for use only in the research setting: MammaPrint from Agendia; Mammostrat from the Clarient Inc....
BioCentury | Sep 25, 2013
Financial News

Biocept files for IPO

...status in detected CTCs using fluorescence in situ hybridization (FISH). Biocept is partnered with the Clarient Inc....
BioCentury | Sep 16, 2013
Company News

Biocept management update

...president and CEO, formerly general manager of North American sales and marketing at General Electric's Clarient...
Items per page:
1 - 10 of 98
BioCentury | Dec 13, 2018
Company News

Management tracks: Ambys, Foghorn

...laboratory director of the genetic testing company since joining as part of the acquisition of Clarient Inc....
BioCentury | Jan 4, 2016
Company News

General Electric, NeoGenomics deal

...NeoGenomics completed its acquisition of General Electric’s Clarient Inc. unit and Clarient’s Clarient Diagnostic Services Inc. subsidiary...
BioCentury | Dec 14, 2015
Company News

General Electric, NeoGenomics deal

...Cancer diagnostic company NeoGenomics will acquire General Electric’s Clarient Inc. unit and Clarient’s Clarient Diagnostic Services Inc...
...on NeoGenomics close of $5.68 on Oct. 20, the day before the deal was announced. Clarient...
...revenue in 2014; NeoGenomics had $87.1 million in revenue for the same period. GE acquired Clarient...
BioCentury | Nov 3, 2014
Company News

General Electric, GlaxoSmithKline deal

...General Electric's Clarient Diagnostic Services Inc. company and GlaxoSmithKline partnered to form a network of clinical...
...laboratories to identify genetic mutations associated with different tumor types. The partners will initially use Clarient's...
...focus on more than 70 melanoma-relevant mutations, including BRAF V600E and BRAF V600K. The first Clarient-certified...
BioCentury | May 5, 2014
Company News

CardioDx management update

...of corporate development and general counsel, formerly SVP of business development and product strategy at Clarient Inc....
BioCentury | Apr 30, 2014
Financial News

CardioDx revives IPO plans

...served in multiple executive management positions, including SVP of business development and product strategy at Clarient Inc....
...now part of Thermo Fisher Scientific Inc. (NYSE:TMO). Prior to that, Ross was CSO at Clarient...
BioCentury | Jan 27, 2014
Company News

Epic Sciences management update

...Jolla, Calif. Business: Diagnostic, Cancer Hired: Michael Rodriguez as CFO, formerly COO of General Electric's Clarient...
BioCentury | Oct 7, 2013
Clinical News

Oncotype DX breast cancer assay regulatory update

...to recommend for use only in the research setting: MammaPrint from Agendia; Mammostrat from the Clarient Inc....
BioCentury | Sep 25, 2013
Financial News

Biocept files for IPO

...status in detected CTCs using fluorescence in situ hybridization (FISH). Biocept is partnered with the Clarient Inc....
BioCentury | Sep 16, 2013
Company News

Biocept management update

...president and CEO, formerly general manager of North American sales and marketing at General Electric's Clarient...
Items per page:
1 - 10 of 98